424B5PYXSCIK 0001782223
Pyxis Oncology, Inc.
Prospectus supplement (424B5) filed .
Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.
Filing facts
- Accession number
- 0001437749-26-031480
- Filer
- Pyxis Oncology, Inc.
- Ticker
- PYXS
- CIK
- 0001782223
- Form type
- 424B5
- Form description
- Prospectus supplement
- Filed at
- September 29, 2026
- Last verified
- September 30, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Pyxis Oncology, Inc.
See all 44 filings from Pyxis Oncology, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1782223/000143774926031480/0001437749-26-031480-index.htm ↗Filer's full EDGAR submission history
EDGAR · Pyxis Oncology, Inc. (0001782223) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001437749-26-031480.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.